🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-02-15
Trial ID
NCT04737655
The purpose of this study is to determine if there is a difference in patie...
Status
Completed
Location
Hospital for Special Surgery, New York
Start Date
2017-01
Trial ID
NCT02996591
Treatments Being Tested
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
The study purpose is to evaluate the effect of QAB149 * NVA237 vs. QAB149 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01699685
The study consists of measurement of antidepressant-induced excessive sweat...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2012-04
Trial ID
NCT01588717
Treatments Being Tested
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
This study will evaluate whether prompt initiation and maintenance of Brezt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-19
Trial ID
NCT05970263
The primary objective of this study is to assess the efficacy of Glycopyrro...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-04
Trial ID
NCT01587079
Treatments Being Tested
This study is a multicenter, randomized, controlled, double-blinded, and pa...
Status
Completed
Location
Multiple Locations
Start Date
2014-06-29
Trial ID
NCT02100280
Treatments Being Tested